Research Article

Preclinical Pharmacokinetics, Biodistribution, and Acute Toxicity Evaluation of Caerin 1.9 Peptide in Sprague Dawley Rats

Table 5

Hematological values of female rats.

ParametersSingle doseRepeated dose
Vehicle control1.0 mg/kg10.0 mg/kg100.0 mg/kg10.0 mg/kg

RBC (1012/L)7.778 ± 0.2197.584 ± 0.5687.954 ± 0.4248.042 ± 0.5616.04 ± 0.37
HCT (%)46.06 ± 0.645.34 ± 3.1346.98 ± 1.2247.16 ± 1.4938.2 ± 1.34
HGB (g/dL)14.92 ± 0.2314.44 ± 1.0614.9 ± 0.2914.96 ± 0.4711.62 ± 0.50
MCV (fL)59.26 ± 1.359.86 ± 0.5659.1 ± 1.7158.8 ± 2.7663.38 ± 2.38
MCH (pg)19.2 ± 0.5819.06 ± 0.2718.78 ± 0.7518.64 ± 119.25 ± 0.69
MCHC (g/dL)32.38 ± 0.331.82 ± 0.4731.76 ± 0.4631.68 ± 0.3330.4 ± 0.46
ABRETIC (109/L)191.58 ± 55.04226.5 ± 33.41192.02 ± 21.07215.84 ± 21.41273.87 ± 31.75
WBC (109/L)7.444 ± 1.5478.022 ± 3.8407.922 ± 1.8657.28 ± 2.16310.67 ± 1.900
ABNEUT (109/L)1.146 ± 0.5121.71 ± 1.5161.128 ± 0.3081.148 ± 0.4342.53 ± 0.45
ABLYMP (109/L)5.988 ± 1.0535.956 ± 2.3366.526 ± 1.925.886 ± 1.8077.64 ± 1.61
ABMONO (109/L)0.18 ± 0.080.228 ± 0.2340.136 ± 0.0340.142 ± 0.0940.23 ± 0.08
ABBASO (109/L)0.006 ± 0.0050.006 ± 0.0050.01 ± 0.0070.008 ± 0.0040.01 ± 0
ABEOS (109/L)0.066 ± 0.0110.072 ± 0.0340.072 ± 0.0320.06 ± 0.0310.16 ± 0.07
PLT (109/L)979.8 ± 82.61081.6 ± 83.21004.4 ± 93.7987 ± 86.11357.67 ± 169.65
MPV (fL)8.92 ± 0.259.02 ± 0.309.28 ± 0.209 ± 0.198.58 ± 0.42
APTT (seconds)16.8 ± 0.6516.94 ± 1.1518.24 ± 1.3617.02 ± 1.4714.9 ± 0.28
PT (seconds)20.04 ± 0.9120.06 ± 0.7519.44 ± 0.7019.72 ± 0.5020.45 ± 1.16

Values are expressed as mean ± SD.